Frontiers in pharmacology , 9 , 557
RetzWRslerMOseCScheragAAlmBPhilipsenAet al
A novel anti-inflammatory role of GPR120 in intestinal epithelial cells
Reach by phone at (833) 482-6464, in-portal chat (AI first, human available on request), and email at [email protected]
Availability: 171 in stock Current findings are derived primarily from preclinical and experimental research settings
As Best Life reported, A previous study published in 2024 found that people using semaglutide are four times more likely to develop a rare but scary eye condition called nonarteritic anterior ischemic optic neuropathy, or NAION for short. This year, researcher and ophthalmologist Bradley Katz , PhD, discovered that both semaglutide and tirzepatide (the active ingredient in Zepbound and Mounjaro) can lead to NAION, as well as papillitis (inflammation of the optic nerve) and paracentral acute middle maculopathy (impacting your eyes blood vessels)